細胞生物學(xué)(COCEBI)發(fā)表權(quán)威、全面和系統(tǒng)的評論。COCEBI幫助專家對當(dāng)前先進的細胞生物學(xué)進行清晰和可讀的合成，以保持最新的進展。專家作者從今天出版的大量信息中注釋最有趣的論文，節(jié)省了寶貴的時間，并讓讀者了解重要的領(lǐng)域。《細胞生物學(xué)當(dāng)前觀點》是《細胞生物學(xué)當(dāng)前觀點與研究》(CO+RE)系列期刊的一部分，是《細胞生物學(xué)當(dāng)前研究》(CRCBIO)最新一期期刊《開放獲取期刊》(open access journal, Current Research in Cell Biology, CRCBIO)的配套期刊。CO+RE期刊利用了當(dāng)前的觀點遺產(chǎn)——卓越的編輯、高影響力和全球影響力——確保它們是廣泛閱讀的資源，是科學(xué)家工作流程不可或缺的一部分。細胞生物學(xué)的最新觀點為研究人員、講師、教師、專業(yè)人士、決策者和學(xué)生提供了寶貴的信息來源。細胞生物學(xué)分為六個主題部分，每個部分每年復(fù)習(xí)一次。主題包括單元結(jié)構(gòu);細胞信號傳導(dǎo);細胞核;膜販運;細胞動力學(xué);細胞分化和疾病。該雜志建立在愛思唯爾卓越的科學(xué)出版聲譽和長期致力于傳播可復(fù)制的生物醫(yī)學(xué)研究，旨在改善人類健康。

Current Opinion in Cell Biology (COCEBI) publishes authoritative, comprehensive, and systematic reviews. COCEBI helps specialists keep up to date with a clear and readable synthesis on current advances cell biology. Expert authors annotate the most interesting papers from the expanding volume of information published today, saving valuable time and giving the reader insight on areas of importance.Current Opinion in Cell Biology is part of the Current Opinion and Research (CO+RE) suite of journals and is a companion to the new primary research, open access journal, Current Research in Cell Biology (CRCBIO). CO+RE journals leverage the Current Opinion legacy—of editorial excellence, high-impact, and global reach—to ensure they are a widely read resource that is integral to scientists’ workflow.Current Opinion in Cell Biology serves as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students. The subject of cell biology is divided into six themed sections, each of which is reviewed once a year. Themes include cell architecture; cell signaling; cell nucleus; membrane trafficking; cell dynamics; and cell differentiation and disease.The journal builds on Elsevier’s reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health.